Form CORRESP - Correspondence:
SEC Accession No. 0001654954-23-010470
Filing Date
2023-08-10
Accepted
2023-08-10 15:26:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 13139
2 tenx_correspimg2.jpg GRAPHIC 2964
  Complete submission text file 0001654954-23-010470.txt   18571
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations